Viruses comprising mutant ion channel protein

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S209100, C435S235100, C435S239000, C435S325000

Reexamination Certificate

active

06872395

ABSTRACT:
A method to prepare viruses lacking ion channel activity is provided.

REFERENCES:
patent: 5994526 (1999-11-01), Meulewaeter et al.
patent: 9610632 (1996-04-01), None
patent: 9640955 (1996-12-01), None
patent: 0053786 (2000-09-01), None
Duff, K.C., et al., “The secondary structure of influenza A M2 transmembrane domain”,FEBS Letters, 311(3), pp. 256-258, (Oct. 1992).
Duff, K.C., et al., “The Transmembrane Domain of Influenza A M2 Protein Forms Amantadine-Sensitive Proton Channels in Planar Lipid Bilayers”,Vilology, 190(1), pp. 485-489, (Sep. 1992).
Grambas, S., et al., “Influence of Amantadine Resistance Mutations on the pH Regulatory Function of the M2 Protein of Influenza A Viruses”,Virology, 191(2), pp. 541-549, (Dec. 1992).
Hay, A.J., et al., “The role of the M2 protein in influenza A virus infection”,Proceedings of the International Conference on Options for the Control of Influenza,Courchevel, pp. 281-288, (1992).
Helenius, A., “Unpacking the Incoming Influenza Virus”,Cell, 69,pp. 577-578, (May 1992).
Holsinger, L.J., et al., “Influenza A Virus M2 Ion Channel Protein: a Structure-Function Analysis”,Journal of Virology, 68(3), pp. 1551-1563, (1994).
Mena, I., et al., “Rescue of a Synthetic Choramphenicol Acetyltransferase RNA into influenza Virus-Like Particles obtained from recombinant plasmids”,J. of Virology,vol. 70, No. 8, XP002150091, 5016-5024, (Aug. 1996).
Neumann, G., et al., “Generation of influenza A Viruses entirely from cloned cDNAs”,Proc. of the Nat'l Aca. of Sciences, USA,vol. 96, XP002150093, 9345-9350, (Aug. 1999).
Neumann, G., et al., “Plasmid-Driven Formation of Influenza Virus-Like Particles”,J. of Virology,vol. 74, No. 1, XP002150094, 547-551, (Jan. 2000).
Neumann, G., et al., “RNA Polymerase I-Mediated Expression of Influenza Viral RNA Molecules”,Virology,vol. 202, No. 1, XP000952667, 477-479, (Jul. 1994).
Neirynck, S., et al., “A universal influenza A vaccine based on the extracellular domain of the M2 protein”,Nature Medicine, 5(10), pp. 1157-1163, (Oct. 1999).
Piller, S.C., et al., “Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid bilayers”,PNAS, 93,pp. 111-115, (Jan. 1996).
Pinto, L.H., et al., “Influenza Virus M2 Protein Has Ion Channel Activity”,Cell, 69,pp. 517-528, (May 1992).
Pleschka, S., et al., “A Plasmid-Based Reverse Gentics System for Influenza A Virus”,J. of Virology,vol. 70, No. 6, XP002150092, 4188-4192, (Jun. 1996).
Sansom, M.S., et al., “Influenza virus M2 Protein: a molecular modelling study of the ion channel”,Protein Engineering, 6(1), pp. 65-74, (1993).
Skehel, J.J., et al., “On the Mechanism of Inhibition of Influenza Virus Replication by Amantadine Hydrochloride”,The Journal of General Virology, 38(1), pp. 97-110, (1977).
Sugrue, R.J., et al., “Specific structural alteration of the influenza haemagglutinin by amantadine”,The EMBO Journal, 9(11), pp. 3469-3476, (1990).
Sugrue, R.J., et al., “Structural Characteristics of the M2 Protein of Influenza A Viruses: Evidence That It Forms a Tetrameric Channel”,Virology, 180,pp. 617-624, (1991).
Takeuchi, K., et al., “Influenza Virus M2 Protein Ion Channel Activity Stabilizes the Native Form of Fowl Plague Virus Hemagglutinin during Intracellular Transport”,Journal of Virology, 68(2), pp. 911-919, (Feb. 1994).
Wang, C., et al., “Ion Channel Activity of Influenza A Virus M2 Protein: Characterization of the Amantadine Block”,Journal of Virology, 67(9), pp. 5585-5594, (Sep. 1993).
Castrucci, M.R., et al., “Reverse Genetics system for generation of an influenza A virus mutant containing a deletion of the carboxyl-Terminal residue of M2 protein”,J. of Virology,vol. 69, No. 5, (May 1995), pp. 2725-2728.
Park, E.K., et al., “The M2 Ectodomain is important for its incorporation into influenza A virions”,J. of Virology,vol. 72, No. 3, (Mar. 1998), pp. 2449-2455.
Pekosz, A., et al., “Influenza C virus CM2 integral membrane glycoprotein is produced from a polypeptide precursor by cleavage of an internal signal sequence”,PNAS,vol. 95, (Oct. 1998), pp. 13233-13238.
Sunstrom, N.A., et al., “Ion Channels formed by NB, an influenza B virus Protein”,J. of Membrane Biology,vol. 150, (Dec. 1996), pp. 127-132.
Sweet, T.M., et al., “Creation of Amantadine resistant clones of influenza type A virus using a new transfection procedure”,J of Virological Methods,vol. 69, (1997), pp. 103-111.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Viruses comprising mutant ion channel protein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Viruses comprising mutant ion channel protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Viruses comprising mutant ion channel protein will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3370536

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.